## Abstract Fiftyβsix children with refractory acute lymphocytic leukemia (ALL) were assessed for remissionβinduction responses to VMβ26 (250 mg/m^2^ per week) in combination with prednisone (40 mg/m^2^ per day) and vincristine (1.5 mg/m^2^ per week). Each child had been treated intensively with st
VM26 therapy in children with drug-refractory lymphocytic leukemia
β Scribed by Gaston Rivera; Gary V. Dahl; Sharon B. Murphy; W. P. Bowman; R. J. Aur; Thomas; L. Avery; J. V. Simone
- Publisher
- Springer
- Year
- 1982
- Tongue
- English
- Weight
- 385 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract We investigated liver function in 27 children with acute lymphocytic leukemia (ALL) after cessation of therapy. Induction therapy consisted of prednisolone + vincristine (VP regimen) alone (16 patients) or with addition of daunorubicin (4 patients) or Lβasparaginase (7 patients). Patien
## Abstract Continuation therapy using intermittent chemotherapy and BCG inoculation was commenced in 28 children with acute lymphocytic leukemia (ALL) immediately after remission induction and βCNS prophylaxis.β At a median followup time of 17 months, 71% remain in total remission and 86% in bone